Show simple item record

dc.contributor.authorMaganga, Joyce
dc.date.accessioned2021-01-21T07:01:18Z
dc.date.available2021-01-21T07:01:18Z
dc.date.issued2020
dc.identifier.urihttp://erepository.uonbi.ac.ke/handle/11295/153790
dc.description.abstractSickle cell disease is a non-communicable disease attracting global public health concern. Chronic effects of sustained hemolytic anemia drive the development of end-organ complications which include heart, brain, kidney, and bones as sickle cell disease patients live longer. Cardiovascular dysfunctions are on the rise leading to a large effect on morbidity and untimely morbidity. Cardiovascular dysfunctions are diagnosed mostly by use of ECHO which is expensive and not found in all the hospitals. Biochemical markers are affordable and can easily be done in all the hospitals. Cardiovascular risks in sickle cell disease patients using biochemical markers have not been documented locally here in Kenyaen_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.titleN-terminal Pro-brain Natriuretic Peptide and Highly Sensitive C-reactive Protein Level in Sickle Cell Disease Patients at Steady Stateen_US
dc.typeThesisen_US
dc.description.departmenta Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States